Tag: <span>Vaccinations</span>

Home / Vaccinations
Health care workers change their minds on vaccinations, study finds
Post

Health care workers change their minds on vaccinations, study finds

by Northwestern University Credit: Unsplash/CC0 Public Domain When the COVID-19 vaccines became available, many health care workers, despite seeing the devastating effects of the virus firsthand, said they did not intend to get vaccinated. But a new Northwestern Medicine study shows how quickly many of them at a large urban health care system changed their...

New demographic data tools tell the story of COVID-19’s impact in the US
Post

New demographic data tools tell the story of COVID-19’s impact in the US

by Doug Donovan,  Johns Hopkins University Demographic data from the Johns Hopkins Coronavirus Resource Center helps users visualize the tragic consequences of COVID-19 in the U.S. by age, race and ethnicity, and gender and sex. Credit: Johns Hopkins University The Johns Hopkins Coronavirus Resource Center today released demographic data and new tools to show the impact...

Post

MANY SUMMER CAMPS DON’T REQUIRE IMMUNIZATIONS

UNIVERSITY OF MICHIGAN “Campers are often in close contact and sharing common spaces, increasing risk for illness outbreaks,” says Carissa Bunke. “As we think about reducing the spread of infectious diseases, children in camps may be an important population to consider.” (Credit: Getty Images) While most children need to show immunization records to attend school,...

COVID-19 and mRNA Vaccines—First Large Test for a New Approach
Post

COVID-19 and mRNA Vaccines—First Large Test for a New Approach

On January 10, Chinese researchers posted the novel coronavirus’ RNA sequence on a preprint server. Immediately, scientists who study genetic vaccines turned their efforts to the emerging pathogen that causes coronavirus disease 2019 (COVID-19). They knew that rapid response genetic platforms could shave precious weeks to months off development, crucial during a pandemic. They were...

COVID-19 and mRNA Vaccines—First Large Test for a New Approach
Post

COVID-19 and mRNA Vaccines—First Large Test for a New Approach

n January 10, Chinese researchers posted the novel coronavirus’ RNA sequence on a preprint server. Immediately, scientists who study genetic vaccines turned their efforts to the emerging pathogen that causes coronavirus disease 2019 (COVID-19). They knew that rapid response genetic platforms could shave precious weeks to months off development, crucial during a pandemic.\ They were...

Post

Iron deficiency during infancy reduces vaccine efficacy

About 40 percent of children around the globe suffer from anemia because they do not consume enough iron. Now, studies by ETH researchers show that iron deficiency also reduces the protection provided by vaccinations. Despite the fact that global immunization programs are now reaching more people than ever, about 1.5 million children still die every...

What the phase 1 trials of the first COVID-19 vaccine really mean
Post

What the phase 1 trials of the first COVID-19 vaccine really mean

Made from viral proteins, Moderna’s COVID-19 vaccine is composed of synthetic viral mRNA. These molecules are injected into people and cellular protein-making machines, called ribosomes, read and translate the mRNA. It’s these proteins that then trigger an immune response. Credit: The Conversation, CC BY-SA Early morning on May 18, Moderna, a biotechnology company, revealed the...

Post

Antibodies from earlier exposures affect response to new flu strains

by John Holden,  University of Texas at Austin We are repeatedly exposed to the influenza virus via infections, vaccinations and our communal environments. The annual flu shot is believed to be the best line of defense, and doctors recommend vaccinations every year because the flu virus is in a constant state of adaptation and mutation, rendering...

Post

Temperature-stable experimental tuberculosis vaccine enters clinical testing

Vaccinations have begun in a Phase 1 human clinical trial testing a freeze-dried, temperature-stable formulation of an experimental tuberculosis (TB) vaccine candidate. The trial is being conducted at the Saint Louis University School of Medicine Center for Vaccine Development and will enroll as many as 48 healthy adult volunteers aged 18 to 55 years. The...